NEW YORKNEW YORK — Regulators in Brazil approved several versions of Angiotech Pharmaceuticals Inc.’s Quill suture product, the company said Thursday. Angiotech said the Quill SRS PDO, Monoderm, ...
The Quill (TM) SRS PDO is a longer-lasting absorbable suture, which istypically used for deeper tissue closures. Angiotech is now able to offer abroad range of PDO suture products with diameters ...
VANCOUVER, March 21, 2014 /CNW/ - Angiotech Pharmaceuticals, Inc. ("ANPI") today announced its financial results for the quarter and year ended December 31, 2013 as well as number of recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results